How Long Does PT-141 (Bremelanotide) Last? Shelf Life & Stability
"Stable" is meaningless without saying stable against what. PT-141 (Bremelanotide) has its own set of degradation routes, and they determine which storage precautions actually matter for it.
In plain English
Worth contrasting with oxytocin here. Both form closed rings, but oxytocin's ring is held by a reactive sulfur bond that can break and swap, while this one is closed by an ordinary stable bond. So the ring is a strength rather than a weakness. Its real vulnerability is light.
What PT-141 (Bremelanotide) actually is
PT-141 has an unusual history. It is a breakdown product of a compound originally developed for research into skin pigmentation, and an unexpected observation during that work redirected attention to the breakdown product, which was then developed as its own line of research.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
Degradation routes specific to PT-141 (Bremelanotide)
- Tryptophan photo-oxidation — the main chemical route for this sequence.
- Slow hydrolysis over extended solution storage.
- Adsorptive loss at dilute working concentrations.
Worth distinguishing from oxytocin: both are cyclic, but PT-141 closes through a lactam (an amide bond) rather than a disulfide. Amide bonds do not undergo the exchange and scrambling chemistry that dominates oxytocin degradation, so the cyclic structure here is a stability asset rather than a liability.
Freeze–thaw tolerance
Aliquot on reconstitution. The lactam ring is chemically robust, so the constraints here are the usual oxidative and interfacial ones.
How storage addresses these routes
Practical window once reconstituted: 2–4 weeks at 2–8 °C. Protect from light — tryptophan photo-oxidation applies.
Full PT-141 (Bremelanotide) storage conditionsWhat PT-141 (Bremelanotide) is studied for
Acts at melanocortin receptors, with MC3R and MC4R the subtypes of research interest.
Distinguished in the literature by acting centrally, unlike vascular-mechanism compounds in adjacent research areas.
Its origin as a metabolite of a pigmentation-research compound is central to understanding its development history.
The lactam bridge restricts conformational freedom, a common strategy for improving receptor selectivity.
Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.
More PT-141 (Bremelanotide) reference
Lyophilized and reconstituted storage conditions, plus the practical working window.
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
Questions specific to this compound — structure, chemistry, and common misconceptions.
Stability reference for other compounds
PT-141 (Bremelanotide) is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.